GSK completes acquisition of Aiolos Bio for up to $1.4 bln :

GSK said on Thursday
it had completed the acquisition of Aiolos Bio, a clinical-stage
biopharmaceutical company focused on respiratory and
inflammatory conditions.
GSK will pay $1...

Related Keywords

London , City Of , United Kingdom , Jason Neely , Aiolos Bio , Pablo Mayo Cerqueiro , Reuters , Jiangsu Hengrui Pharmaceuticals Co Ltd , Markets ,